Building a Better Trader - Volume 1: Laying the Foundation

Posted on by The INO.com Team

Cut your losses short and let your winners run wild. It sounds so simple, yet even some of the most experienced traders cannot explain how to do it well. In this information-packed video, veteran trading pro Glen Ring cuts to the chase and reveals some specific methods you can use to jump on board the big trends and ride them down the rails to major profits. More importantly, he explains how to use each of these methods to build better trades. After introducing you to the key components of successful trading, Glen will discuss why it's so important that your trading has structure. Finally, he'll show you how to differentiate between the management and mechanics of the business of trading.

WATCH NOW: Building a Better Trader - Volume 1: Laying the Foundation

Best,
The INOTV Team

The Gold-to-Silver Ratio: A Truly Generational Opportunity

Posted on by admin

Precious metals expert Michael Ballanger says that owning silver versus owning gold is a high-probability trade that could be the 2016 Trade of the Year.

Daily GDX Chart

This week's Gong Show in the global financial markets reminds me of the early 1980s before the advent of the Internet or online trading or blogs and especially before 30-something financial "advisors" were allowed to go on the national (and international) airwaves or Internet websites and babble on for what seem like days how "The Fed has our back!" as an excuse for buying stocks at 23 times forward earnings.

Back then, at 4:15 every Friday night, there would be a line-up of brokers and analysts (even the janitor) next to the old teletype machine (I am imagining more than a few raised eyebrows among the kids out there as they quickly Google search "teletype machine" on their Smartphones while sipping a $10 cup of fancy-ass coffee) in expectation of the all-important "Money Supply" numbers that everyone supposed was going to give them a hint as to when interest rates would start to decline from 16%-plus nosebleed levels of the early 1980s. Continue reading "The Gold-to-Silver Ratio: A Truly Generational Opportunity" →

Weekly Futures Recap With Mike Seery

Posted on by The INO.com Team

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

10-Year Note Futures

The 10 year note in the June contract settled last Thursday in Chicago at 129 7/32 while currently trading at 130 12/32 trading higher 4 out of the last 5 trading sessions as I’ve been recommending a bullish position from around 129/25 as I think interest rates in the United States are going lower which is an amazing thing to state. Worldwide interest rates in many different countries have gone negative which is the first time in history that has happened as I think the world is chasing interest rates and at 1.77% the U.S still looks expensive in my opinion so play this to the upside as I’m looking to add more contracts once the chart structure improves, therefore, lowering monetary risk. If you took the original recommendation place your stop loss below the 10 day low which currently stands 128/20/30 as the chart structure will not improve for another 4 days as you will have to be patient with the monetary risk as I think prices will retest last month’s high around 132/16 as the bullish trend remains intact in my opinion. Continue reading "Weekly Futures Recap With Mike Seery" →

Crude Oil Triggers A Sell Signal and Tesla Blows Away Skeptics

Posted on by The INO.com Team

Hello MarketClub members everywhere!

Well, here we are, the 1st of April and I don't have an April fools joke to share with you. Q1 will go down in history as one of the best first quarters since the 1930s. So what propelled this market to push so much on the upside in Q1? To be honest with you I'm not sure; maybe it was the prospect of ongoing cheap money from the FED or something else. When you look at hedge fund managers and other professional traders, nobody was expecting such a strong quarter. Now that Q1 is in the record books it is time to start looking at what is ahead for this the stock market.

MarketClub's Mid-day Market Report

In today's video, I will be analyzing crude oil (NYMEX:CL.K16.E), which triggered a sell signal and Tesla Motors Inc. (NASDAQ:TSLA) which triggered a buy signal today. I will also be covering the usual suspects. Continue reading "Crude Oil Triggers A Sell Signal and Tesla Blows Away Skeptics" →

TIME Magazine Showcases Immunotherapy – Immunotherapy ETF Now Trading

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction

Immunotherapy has garnered national attention recently by being showcased on the front cover of Time magazine. Immunotherapy has been an emerging and exciting therapeutic area that has experienced massive growth in terms of research and development expenditures and the sheer number of clinical trials. Immunotherapy ushers in a new class of potentially promising therapies by harnessing the body’s immune system to recognize and eradicate debilitating diseases, specifically cancer and chronic viral infections. This immunotherapy approach may inevitably result in a paradigm shift from traditional medical intervention. Immunotherapy possesses holistic attributes by harnessing the body’s immune system to contend with or in some cases prevent disease. In addition to the holistic aspects, immunotherapy has been shown to have a favorable side effect profile and best-in-class efficacy across many different disease states. These therapies may provide powerful technology to contend with a host of diseases, and in a future state, may potentially serve as a preventative technology similar to a traditional vaccine. Immunotherapy has evolved into many different classifications with differing modalities over the past few years, which has given rise to a growing number small-cap biotechnology companies with potential investment opportunities via an immunotherapy ETF. In late 2015, Loncar Cancer Immunotherapy ETF launched (NASDAQ:CNCR) and provides investors with an opportunity to invest in this unique cohort. Continue reading "TIME Magazine Showcases Immunotherapy – Immunotherapy ETF Now Trading" →